Clinical Trial Update: MDMA-Assisted Massed Exposure Therapy for PTSD [Phase 2]

View source ↗

Summary

A phase 2 clinical trial is exploring MDMA-assisted massed exposure therapy for post-traumatic stress disorder and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Emory University | Conditions: Post Traumatic Stress Disorder | Phase 2 | Status: RECRUITING